Clinical Trial Update: Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating Obeldesivir for treating RSV infection in nonhospitalized adults was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Obeldesivir (Obeldesivir)

Snippet

Sponsor: Gilead Sciences | Conditions: RSV Infection | Phase 2 | Status: TERMINATED